
Sign up to save your podcasts
Or


This week: how accurate is clinical gestalt (https://www.ncbi.nlm.nih.gov/pubmed/31208974), canagliflozin and renal outcomes in high risk patients (https://www.ncbi.nlm.nih.gov/pubmed/30990260) and whether oral immunotherapy for peanut allergy is safe and effective (https://www.ncbi.nlm.nih.gov/pubmed/31030987).
By Mark Ebell4.7
9292 ratings
This week: how accurate is clinical gestalt (https://www.ncbi.nlm.nih.gov/pubmed/31208974), canagliflozin and renal outcomes in high risk patients (https://www.ncbi.nlm.nih.gov/pubmed/30990260) and whether oral immunotherapy for peanut allergy is safe and effective (https://www.ncbi.nlm.nih.gov/pubmed/31030987).

135 Listeners

705 Listeners

506 Listeners

299 Listeners

306 Listeners

265 Listeners

3,360 Listeners

1,152 Listeners

197 Listeners

93 Listeners

517 Listeners

373 Listeners

253 Listeners

373 Listeners

313 Listeners